{"id":"https://openalex.org/W1978383327","doi":"https://doi.org/10.1177/0091270009340782","title":"Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects","display_name":"Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects","publication_year":2009,"publication_date":"2009-11-26","ids":{"openalex":"https://openalex.org/W1978383327","doi":"https://doi.org/10.1177/0091270009340782","mag":"1978383327","pmid":"https://pubmed.ncbi.nlm.nih.gov/19940229"},"language":"en","primary_location":{"id":"doi:10.1177/0091270009340782","doi":"https://doi.org/10.1177/0091270009340782","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270009340782","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101880742","display_name":"Zhenhua Xu","orcid":"https://orcid.org/0000-0002-3415-0133","observed_orcids":["https://orcid.org/0000-0002-3415-0133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenhua Xu","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, PA 19355, USA","Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, PA 19355, USA","institution_ids":[]},{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042741534","display_name":"Qingmin Wang","orcid":"https://orcid.org/0000-0002-6062-3766","observed_orcids":["https://orcid.org/0000-0002-6062-3766","https://orcid.org/0009-0006-3036-4683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingmin Wang","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037777681","display_name":"Yanli Zhuang","orcid":"https://orcid.org/0000-0003-4700-5207","observed_orcids":["https://orcid.org/0000-0003-4700-5207"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanli Zhuang","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111594814","display_name":"Bart Frederick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bart Frederick","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Yan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Yan","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082838669","display_name":"Esther Bouman\u2010Thio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Bouman\u2010Thio","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027075504","display_name":"Joseph C. Marini","orcid":"https://orcid.org/0000-0002-2827-0729","observed_orcids":["https://orcid.org/0000-0002-2827-0729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph C. Marini","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083402759","display_name":"Monica Keen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Keen","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Snead","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Snead","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076610847","display_name":"Hugh M. Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugh M. Davis","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031629161","display_name":"Honghui Zhou","orcid":"https://orcid.org/0000-0002-5149-1458","observed_orcids":["https://orcid.org/0000-0002-5149-1458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Honghui Zhou","raw_affiliation_strings":["Centocor Research and Development Inc, Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centocor Research and Development Inc, Malvern, Pennsylvania","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":2.3427,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.88031132,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"50","issue":"3","first_page":"276","last_page":"284"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5282999873161316,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5282999873161316,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.2468000054359436,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.11050000041723251,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/golimumab","display_name":"golimumab","score":1.0},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9649999737739563},{"id":"https://openalex.org/keywords/absolute-bioavailability","display_name":"absolute bioavailability","score":0.7820000052452087},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/injection-site","display_name":"injection site","score":0.8109999895095825},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.6919999718666077},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.7039999961853027},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9350000023841858},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6209999918937683},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.922295093536377},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9002708196640015},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8402777910232544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6244605779647827},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4854043424129486},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.43333712220191956},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.41629764437675476},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37977343797683716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32341498136520386},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.2194150686264038},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007118","descriptor_name":"Immunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007145","descriptor_name":"Immunoglobulin kappa-Chains","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0091270009340782","doi":"https://doi.org/10.1177/0091270009340782","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270009340782","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:19940229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19940229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W28067590","https://openalex.org/W1586699825","https://openalex.org/W1966224256","https://openalex.org/W1989958259","https://openalex.org/W1992628263","https://openalex.org/W2027454708","https://openalex.org/W2028547258","https://openalex.org/W2040401921","https://openalex.org/W2044680171","https://openalex.org/W2044749789","https://openalex.org/W2050478039","https://openalex.org/W2052863900","https://openalex.org/W2057926043","https://openalex.org/W2071955492","https://openalex.org/W2072738451","https://openalex.org/W2075888720","https://openalex.org/W2081148269","https://openalex.org/W2116619489","https://openalex.org/W2127728541","https://openalex.org/W2129202470","https://openalex.org/W2150206066","https://openalex.org/W2158131108","https://openalex.org/W2193872144","https://openalex.org/W2502670554","https://openalex.org/W2769111992"],"related_works":["https://openalex.org/W1853585227","https://openalex.org/W1523486205","https://openalex.org/W2062420239","https://openalex.org/W2160360641","https://openalex.org/W3173669442","https://openalex.org/W3179771583","https://openalex.org/W3014739999","https://openalex.org/W2066751846","https://openalex.org/W1989677012","https://openalex.org/W4405384730"],"abstract_inverted_index":{"This":[0],"study":[1],"characterized":[2],"the":[3,31,96,105,109,136,186,202,205],"pharmacokinetics":[4],"(PK)":[5],"of":[6,34,55,139,176,207,214],"golimumab,":[7],"an":[8,208],"antitumor":[9],"necrosis":[10],"factor":[11],"alpha":[12],"human":[13],"IgG1kappa":[14],"monoclonal":[15],"antibody,":[16],"after":[17],"a":[18,52],"single":[19,53],"intravenous":[20],"(IV)":[21],"or":[22,66],"subcutaneous":[23],"(SC)":[24],"administration":[25,68,166,213],"in":[26,197,204],"healthy":[27,44],"subjects":[28],"and":[29,104,125,141,148,164,168,181],"determined":[30],"absolute":[32],"bioavailability":[33,175],"SC":[35,67,134,163,177,212],"golimumab":[36,56,101,178],"delivered":[37],"at":[38,69],"3":[39,187],"different":[40,70],"anatomical":[41],"regions.":[42],"Seventy-eight":[43],"adult":[45],"males":[46],"were":[47,88,120,143],"randomly":[48],"assigned":[49],"to":[50,117],"receive":[51],"dose":[54],"100":[57,191],"mg":[58,192],"by":[59],"IV":[60,94,165],"(30-minute":[61],"infusion,":[62],"n":[63,74,78,82],"=":[64,75,79,83],"23)":[65],"sites":[71],"(upper":[72],"arm,":[73],"18;":[76,80],"abdomen,":[77],"thigh,":[81],"19).":[84],"Serial":[85],"blood":[86],"samples":[87],"collected":[89],"for":[90,162,185,211],"PK":[91],"characterization.":[92],"Following":[93],"administration,":[95,135],"mean":[97,106,137,174],"maximum":[98],"observed":[99],"serum":[100],"concentration":[102,110],"(C(max))":[103],"area":[107],"under":[108],"versus":[111],"time":[112,115],"curves":[113],"from":[114],"zero":[116],"infinity":[118],"(AUC(0-infinity))":[119],"29.5":[121],"+/-":[122,127,145,150],"5.8":[123],"microg/mL":[124,147],"195.9":[126],"48.9":[128],"microg":[129,152],"x":[130,153],"d/mL,":[131,154],"respectively.":[132,155],"After":[133],"values":[138],"C(max)":[140],"AUC(0-infinity)":[142],"6.3":[144],"2.8":[146],"100.1":[149],"29.2":[151],"The":[156,172],"median":[157],"terminal":[158],"half-life":[159],"was":[160,179,183,193],"similar":[161,184],"(10.9":[167],"11.8":[169],"days,":[170],"respectively).":[171],"overall":[173],"51%,":[180],"absorption":[182],"injection":[188,209],"sites.":[189],"Golimumab":[190],"generally":[194],"well":[195],"tolerated":[196],"this":[198],"study.":[199],"Results":[200],"support":[201],"flexibility":[203],"choice":[206],"site":[210],"golimumab.":[215]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}